Clinical Trial of PfSPZ Vaccine Administered by Direct Venous Inoculation: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naive Adults.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanaria
- 25 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.
- 25 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.
- 25 Aug 2017 Status changed from recruiting to active, no longer recruiting.